Endowed Professor (W3) of Cancer Research (Scientific Director of RBCT, tenured position)

Endowed Professor (W3) of Cancer Research (Scientific Director of RBCT, tenured position)

University of Tübingen − Faculty of Medicine

Tübingen, Germany

The Faculty of Medicine at the University of Tübingen and the Robert Bosch Stiftung, Stuttgart invite applications for a position at the newly founded Robert Bosch Center for Tumor Diseases in Stuttgart (RBCT) as an

Endowed Professor (W3) of Cancer Research (Scientific Director of RBCT, tenured position)

RBCT in Stuttgart is part of the Comprehensive Cancer Center Tübingen-Stuttgart (CCC), jointly run by the Medical Faculty / University Hospital Tübingen and Robert Bosch Hospital Stuttgart, funded by the German Cancer Aid as a Center of Excellence in Interdisciplinary Oncology and the Robert Bosch Stiftung. Furthermore Tübingen is a member of the German Cancer Consortium (DKTK) led by the German Cancer Research Center (DKFZ).

The Robert Bosch Stiftung, one of the major foundations in Europe, is associated with a private company, the Robert Bosch GmbH. The Robert Bosch Stiftung and its subsidiary Robert Bosch Hospital (RBK) have established the RBCT under the entity of Robert Bosch Gesellschaft für medizinische Forschung in collaboration with the University of Tübingen and the DKFZ in Heidelberg, strongly supported by the Bosch Company. The RBCT aims for the best possible individualized treatment for patients by rapidly translating promising research findings into cancer-therapy. The RBCT’s goal is to become a highly recognized partner in international networks of the best cancer research centers. We are seeking an innovative leader in cancer research to serve as director to establish and run the scientific arm of the new RBCT.

The candidates for this position should hold an MD or PhD in a relevant discipline for modern cancer research and should have:

  • a sound interest and track record in facilitating the path from biological discoveries in molecular oncology to clinical trials, by including non-medical disciplines and technologies, such as information technology, artificial intelligence or intelligent sensor technology
  • an outstanding international research reputation and profound knowledge in one or several fields of cutting-edge cancer research
  • excellent communication skills and networking abilities
  • worked in distinguished academic research institutions or companies, and demonstrated longstanding and excellent leadership and management qualities
  • a strong track record in raising third party funding, including prestigious grants, such as ERC, DFG, Wellcome Trust and others
  • a track record in attracting independent young research group leaders, such as DFG-Emmy-Noether groups, ERC starting grant holders and the like
  • a strategic vision for research and the development of the RBCT
  • proven teaching aptitude
  • Habilitation or equivalent postdoctoral qualification

The RBCT-Director’s responsibilities will include:

  • developing an innovative translational cancer research program suited to reach the RBCT’s goals
  • leading and recruiting associated large teams in different disciplines in a global framework
  • close collaboration with the clinical director of RBCT and the respective medical departments in the RBK, the associated Institute for Clinical Pharmacology (IKP, Prof. M. Schwab) and our partners in Heidelberg and Tübingen to bring the latest research findings to the patients
  • active contribution to the research of CCC and DKTK as well as to running and future collaborative research groups and international research projects

The University of Tübingen and the Robert Bosch Krankenhaus are particularly interested in applications from female candidates and and therefore encourage qualified women to apply.

In line with its internationalization agenda, we welcome applications from researchers outside Germany.

Candidates with disabilities will be given preference if the qualifications of these candidates are equivalent to those of a non-disabled candidate.
Further information on required documentation can be found in our application guidelines at www.medizin.uni-tuebingen.de/de/medizinische-fakultaet/struktur-und-berufung. The German-language advertisement is the sole legally binding advertisement of this position.

For further information regarding RBCT you may contact: Dr. Ingrid Wünning Tschol (Ingrid.wuenning@ bosch-stiftung.de) or Professor Dominik Alscher (Dominik.alscher@rbk.de)

Please send your entire application (with application form) as a single, electronic PDF file to: berufungen.dekanat@med.uni-tuebingen.de. The deadline for applications is January 31st, 2019.

Enquiries may be sent to this address:

Dean of the Faculty of Medicine
University of Tübingen
Professor Dr. med. Ingo B. Autenrieth
Geissweg 5
72076 Tübingen, GERMANY

Favorite

Apply with CV and Cover Letter

Fields with a * are mandatory
Must be a .doc, .docx, or .pdf file and no larger than 1MBMust be a .doc, .docx, or .pdf file and no larger than 1MB
Position

Endowed Professor (W3) of Cancer Research (Scientific Director of RBCT, tenured position)